
Quarterly Result30 Oct 2026, 05:03 pm
Anuh Pharma Board Approves Q2 FY27 Unaudited Results
AI Summary
Anuh Pharma Limited's Board of Directors met on October 30, 2026, to consider and approve the Unaudited Financial Results for the quarter and half-year ended September 30, 2026. The board also approved a request from Nina Vijay Shah, a shareholder from the Promoter Group, to withdraw her application for reclassification, confirming her continued status within the Promoter Group. The meeting commenced at 1:00 p.m. and concluded at 4:10 p.m.
Key Highlights
- Board approved unaudited financial results for Q2 FY27 and H1 FY27.
- Shareholder Nina Vijay Shah's reclassification withdrawal approved.
- Shareholder will continue to remain part of the Promoter Group.
- Meeting concluded with no significant financial figures mentioned in the narrative.
Price Impact
More from ANUHPHR